Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Clinical trial NCT06316297 · RECRUITING
Trial details
- NCT number
- NCT06316297
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-05
- Primary completion
- 2028-11-30
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.